External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Respiratory ATS 2026
Roche and Genentech at

ATS 2026

May 15 - May 20
Orlando, USA
site.thoracic.org
We will be contributing to topics related to
Respiratory Infectious Disease
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
01:15 PM
Duration 105mins Orlando, USA
Serum soluble ST2 and blood eosinophils are pharmacodynamic biomarkers of astegolimab treatment in COPD
Michele Grimbaldeston
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:15 PM
Duration 120mins Orlando, USA
Astegolimab for chronic obstructive pulmonary disease in patients with a history of frequent exacerbations: the Phase III, randomized, double-blind, placebo-controlled, multicenter ARNASA trial
Alberto Papi
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Orlando, USA
Astegolimab decreases exacerbation risk in patients with COPD with frequent exacerbations, irrespective of blood eosinophil count: Pooled analysis of the pivotal randomized trials ALIENTO and ARNASA
Jadwiga A. Wedzicha
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 12mins Orange County Convention Center, Orlando, Florida. W110B (Level I, OCCC West Concourse)
Astegolimab for chronic obstructive pulmonary disease (COPD) in patients with a history of frequent exacerbations: the phase III, randomized, double-blind, placebo-controlled, multicenter ARNASA trial
Alberto Papi
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 12mins Orange County Convention Center, Orlando, Florida. W110B (Level I, OCCC West Concourse)
Astegolimab decreases exacerbation risk in patients with COPD with frequent exacerbations, irrespective of blood eosinophil count: Pooled analysis of the pivotal randomized trials ALIENTO and ARNASA
Jadwiga A. Wedzicha
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:15 PM
Duration 120mins Orlando, USA
Astegolimab improves HRQoL in patients with COPD: evaluating SGRQ-C scores in ALIENTO and ARNASA
Frank C. Sciurba
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 12mins Orange County Convention Center, Orlando, Florida. W110A (Level I, OCCC West Concourse)
Astegolimab improves HRQoL in patients with COPD: evaluating SGRQ-C scores in ALIENTO and ARNASA
Frank C. Sciurba
Respiratory | Chronic Obstructive Pulmonary Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:15 PM
Duration 120mins Orlando, USA
Effectiveness of Rapid Multiplex Biomarker Panels to Predict Acute Respiratory Distress Syndrome Sub-phenotypes: A Pilot Study
Deepthi Nacharaju
Infectious Disease | Sepsis

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.